Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025 – Bristol Myers Squibb
- Bristol Myers Squibb Presents Real-World Outcomes of Camzyos (mavacamten) Across Four Continents at the European Society of Cardiology (ESC) Congress 2025 Bristol Myers Squibb
- Will Camzyos Strengthen BMY’s Cardiovascular Portfolio? Yahoo Finance
- Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025 BioSpace